NCT03492944View on ClinicalTrials.gov

Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason

Active, not recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

June 12, 2024

Study Completion Date

February 28, 2026

Conditions
Crohn Disease
Interventions
DRUG

Ultrasound Microbubble Contrast Agent

Patients undergoing a clinically ordered CT or MRI Enterography for Crohn disease will be recruited to undergo a contrast enhanced ultrasound study of the bowel

DEVICE

Ultrasound Imaging

Patients undergoing a clinically ordered CT or MRI Enterography for Crohn disease will be recruited to undergo a contrast enhanced ultrasound study of the bowel

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER